|
Market Closed -
Japan Exchange
12:00:00 14/05/2026 pm IST
|
5-day change
|
1st Jan Change
|
|
2,582.00 JPY
|
-5.27%
|
 |
-1.32%
|
-22.88%
|
|
11/05 |
Jefferies Adjusts Daiichi Sankyo's Price Target to 3,100 Yen from 3,600 Yen, Keeps at Buy
|
MT
| |
06/05 |
Jefferies Adjusts Daiichi Sankyo's Price Target to 3,600 Yen From 4,600 Yen, Keeps at Buy
|
MT
| |
19/25/19 |
Daiichi Sankyo Company, Limited Announces DS-3939 Shows Promising Preliminary Clinical Activity in Patients with Advanced Solid Tumors in Phase 1/2 Trial
|
CI
| |
07/25/07 |
Jefferies Adjusts Daiichi Sankyo's Price Target to 6,300 Yen From 6,000 Yen, Keeps at Buy
|
MT
| |
07/25/07 |
Daiichi Sankyo Company, Limited Submits Supplemental New Drug Application to Japan's Ministry of Health, Labour and Welfare for ENHERTU®
|
CI
| |
01/25/01 |
Daiichi Sankyo and Astrazeneca's Supplemental Biologics License Application Accepted in the U.S. for Patients with High-Risk Her2 Positive Early-Stage Breast Cancer Prior to Surgery
|
CI
| |
02/25/02 |
Jefferies Adjusts Daiichi Sankyo's Price Target to 6,000 Yen From 7,600 Yen, Keeps at Buy
|
MT
| |
04/24/04 |
Jefferies Adjusts Daiichi Sankyo's Price Target to 7,600 Yen From 6,600 Yen, Keeps at Buy
|
MT
| |
24/24/24 |
Jefferies Adjusts Daiichi Sankyo’s Price Target to 6,600 Yen From 5,600 Yen, Keeps at Buy
|
MT
| |
21/24/21 |
Jefferies Adjusts Daiichi Sankyo’s Price Target to 5,600 Yen From 4,800 Yen, Keeps at Buy
|
MT
| |
04/23/04 |
Jefferies Upgrades Daiichi Sankyo to Buy From Hold, Adjusts Price Target to 4,800 Yen From 4,300 Yen
|
MT
| |
23/23/23 |
Jefferies Adjusts Daiichi Sankyo’s Price Target to 4,300 Yen From 3,900 Yen, Keeps at Hold
|
MT
| |
25/23/25 |
Jefferies Downgrades Daiichi Sankyo to Hold From Buy, Adjusts Price Target to 1,900 Yen From 2,000 Yen
|
MT
| |
13/23/13 |
Jefferies Adjusts Daiichi Sankyo’s Price Target to 4,800 Yen From 5,300 Yen, Keeps at Buy
|
MT
| |
14/22/14 |
Jefferies Adjusts Daiichi Sankyo's Price Target to 5,300 Yen From 4,300 Yen, Keeps at Buy
|
MT
|
No results for this search Select your edition All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
| 
